Robotic-assisted cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a minimally invasive approach for peritoneal carcinomatosis in patients with low burden disease
Surgical Endoscopy · 2026-08 · 40 (8) · 6658-6665
DOI: 10.1007/s00464-026-12975-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Endoscopy, online erschienen am 09.06.2026. Verfasst von Andrea Bertolucci und 4 weiteren Autor:innen. Beteiligte Einrichtung: General and Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy, Robotic Surgical Procedures. Die Arbeit nennt 43 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: Peritoneal carcinomatosis (PC) presents a significant challenge and is often associated with poor prognosis. Cytoreductive surgery with heated intraperitoneal chemotherapy (CRS-HIPEC) stands as a well-established treatment modality for various forms of PC. The peritoneal cancer index (PCI) is used to assess the intraperitoneal disease burden, with evidence suggesting a linear correlation with overall survival, particularly in colorectal cancers with peritoneal metastasis. Similarly, completeness of cytoreduction (CC) is assessed post-resection to quantitatively measure residual disease in the abdomen. There has been a growing trend toward minimally invasive CRS-HIPEC, though achieving an accepted CC using this approach has been less frequently reported. This article describes the experience at our institution after ten cases of robotic-assisted CRS-HIPEC. MATERIALS AND METHODS: Data from the ten consecutive R-CRS-HIPEC were retrospectively collected. Comprehensive preoperative imaging and multidisciplinary team deliberations were conducted for case selection. Mini-invasive robotic CRS-HIPEC was considered only for patients exhibiting a limited amount of PC, as evidenced by prior laparoscopy (PCI < 10). To compare surgical outcomes with a homogeneous population of patients undergoing open CRS and HIPEC, 18 consecutive patients treated in the pre-robotic era were retrospectively included, all with PCI < 10 and histology consistent with appendiceal-origin neoplasms. RESULTS: No perioperative complications were noted, and all patients were discharged within seven days of the operation. CONCLUSIONS: Robotic-assisted CRS-HIPEC for appendiceal mucinous neoplasms in highly selected patients is a safe and feasible procedure. A low intraperitoneal tumor burden in patients with intraperitoneal mucinous neoplasms emerges as a mandatory prerequisite to approach CRS-HIPEC with a robotic approach. We endorse ongoing investigation and future prospective clinical trials employing this technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General and Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- General and Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. n_ramacciotti@libero.it.
Zitieren
APA
Bertolucci, A., Ramacciotti, N., Piccini, L., Rreka, E., & Lippolis, P. V. (2026). Robotic-assisted cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a minimally invasive approach for peritoneal carcinomatosis in patients with low burden disease. Surgical Endoscopy, 40(8), 6658-6665. https://doi.org/10.1007/s00464-026-12975-3
Vancouver
Bertolucci A, Ramacciotti N, Piccini L, Rreka E, Lippolis PV. Robotic-assisted cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a minimally invasive approach for peritoneal carcinomatosis in patients with low burden disease. Surgical Endoscopy. 2026;40(8):6658-6665. doi:10.1007/s00464-026-12975-3
BibTeX
@article{Bertolucci2026,
author = {Bertolucci, Andrea and Ramacciotti, Niccolò and Piccini, Lorenzo and Rreka, Erion and Lippolis, Piero Vincenzo},
title = {Robotic-assisted cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a minimally invasive approach for peritoneal carcinomatosis in patients with low burden disease},
journal = {Surgical Endoscopy},
year = {2026},
volume = {40},
number = {8},
pages = {6658--6665},
doi = {10.1007/s00464-026-12975-3}
}
EUVIMED